Taking just under half of its shelf registration down, Orchid BioSciences Inc. is selling about 6 million shares in a private placement that will gross nearly $36 million. Robertson Stephens Inc., of ...
Modifying a patient’s DNA is no longer just for science fiction novels. The CRISPR gene editing technique developed by Jennifer Doudna and Emmanuelle Charpentier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results